Skip to main content

Advertisement

Log in

Thrombotic microangiopathy in sickle cell disease crisis

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Thrombotic microangiopathy (TMA) in patients with sickle cell disease (SCD) is a rare complication. These patients manifest microangiopathic hemolytic anemia (MAHA) with laboratory evidence of hemolytic anemia, schistocytosis, and thrombocytopenia. This is the first report of the syndrome in a group of these patients. A retrospective chart analysis of 10 consecutively diagnosed patients in SCD crisis who were referred for therapeutic plasma exchange (TPE) after developing MAHA was done. Patients had chest pain, respiratory distress, fever, pulmonary infiltrates, jaundice, and neurological dysfunction with abnormal liver function and coagulation tests. MAHA was diagnosed after a median hospital stay of 5 days. Nine patients recovered completely following TPE with fluid replacement by fresh frozen plasma with or without cryo-poor plasma. Incomplete response to TPE in one case was due to the development of fresh complications. During a median follow-up period of 77 months, there was one recurrent episode and one death in SCD crisis but without evidence of MAHA. TMA is not a very rare complication among Bahraini SCD patients in crisis. Characteristic features of this disorder are acute chest syndrome, organ failure, leuco-erythroblastosis, and a combination of thrombocytopenia, LDH level >1,000 U/l, and schistocytes in blood smears. Management with TPE usually leads to complete recovery with little chance of short-term recurrence. Multiple pathogenetic mechanisms leading to increased von Willebrand factor and its multimers may form the basis of this syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Levine SP (2004) Thrombotic thrombocytopenic purpura and other forms of nonimmunologic platelet destruction. In: Greer JP, Lee GR, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader B (eds) Wintrobe’s Clinical Hematology, 11th edn. Lippincott, Philadelphia, pp 1555–1564

    Google Scholar 

  2. Nguyen TC, Han YY (2011) Plasma exchange therapy for thrombotic microangiopathies. Organogenesis 7:28–31

    Article  PubMed  Google Scholar 

  3. Sadler JE (2008) Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood 112:11–18

    Article  PubMed  CAS  Google Scholar 

  4. Zheng XL, Sadler JE (2008) Pathogenesis of thrombotic microangiopathies. Annu Rev Pathol 3:249–277

    Article  PubMed  CAS  Google Scholar 

  5. Sadler JE (2006) Thrombotic thrombocytopenic purpura: a moving target. Hematology Am Soc Hematol Educ Program 2006:415–420

    Article  Google Scholar 

  6. Sadler JE, Moake JL, Miyata T, George JN (2004) Recent advances in thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program 2004:407–423

    Article  Google Scholar 

  7. Fujimura Y, Matsumoto M (2010) Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998–2008. Intern Med 49:7–15

    Article  PubMed  Google Scholar 

  8. Bolanos-Meade J, Keung YK, Lopez-Arvizu C, Florendo R, Cobos E (1999) Thrombotic thrombocytopenic purpura in a patient with sickle cell crisis. Ann Hematol 78:558–559

    Article  PubMed  CAS  Google Scholar 

  9. Geigel EJ, Francis CW (1997) Reversal of multiorgan dysfunction in sickle cell disease with plasma exchange. Acta Anaesthesiol Scand 41:647–650

    Article  PubMed  CAS  Google Scholar 

  10. Chehal A, Taher A, Shamseddine A (2002) Sicklemia with multiorgan failure syndrome and thrombotic thrombocytopenic purpura. Hemoglobin 26:345–351

    Article  PubMed  CAS  Google Scholar 

  11. Chinowsky MS (1994) Thrombotic thrombocytopenic purpura associated with sickle cell-hemoglobin C disease. South Med J 87:1168–1171

    Article  PubMed  CAS  Google Scholar 

  12. Lee HE, Marder VJ, Logan LJ, Friedman S, Miller BJ (2003) Life threatening thrombotic thrombocytopenic purpura (TTP) in a patient with sickle cell-hemoglobin C disease. Ann Hematol 82:702–704

    Article  PubMed  CAS  Google Scholar 

  13. Shome DK, Al Ajmi A, Darwish FA, Ravishekhar K, Zaman A, Malik N (2004) Microangiopathic haemolytic anaemia in sickle cell disease. Abstract Book 9th Congress of the European Hematology Association. Haematologica 89(supplement no. 5):S80

    Google Scholar 

  14. Al-Arrayed S, Hafadh N, Amin S, Al-Mukhareq H, Sanad H (2003) Student screening for inherited blood disorders in Bahrain. East Mediterr Health J 9:344–352

    PubMed  CAS  Google Scholar 

  15. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP (1994) Mortality in sickle cell disease—life expectancy and risk factors for early death. N Engl J Med 330:1639–1644

    Article  PubMed  CAS  Google Scholar 

  16. Allford SL, Hunt BJ, Rose P, Machin SJ, Haemostasis and Thrombosis Task Force, British Committee for Standards in Haematology (2003) Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. Br J Haematol 120:556–573

    Article  PubMed  Google Scholar 

  17. Franchini M, Lippi G, Manzato F (2006) Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation. Thromb J 4:4

    Article  PubMed  Google Scholar 

  18. Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, Nickerson B, Orringer E, McKie V, Daeschner C, Manci EA (2000) Causes and outcomes of the acute chest syndrome in sickle cell disease. N Engl J Med 342:1855–1865

    Article  PubMed  CAS  Google Scholar 

  19. Boga C, Kozanoglu I, Ozdogu H, Ozyurek E (2007) Plasma exchange in critically ill patients with sickle cell disease. Transfus Apher Sci 37:17–22

    Article  PubMed  CAS  Google Scholar 

  20. Hassell KL, Eckman JR, Lane PA (1994) Acute multiorgan failure syndrome: a potentially catastrophic complication of severe sickle cell pain episodes. Am J Med 96:155–162

    Article  PubMed  CAS  Google Scholar 

  21. Hiran S (2005) Multiorgan dysfunction in sickle cell disease. J Assoc Phys India 53:19–22

    Google Scholar 

  22. Hovinga JA, Studt JD, Alberio L, Lämmle B (2004) von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience. Semin Hematol 41:75–82

    Article  Google Scholar 

  23. Lämmle B, Kremer Hovinga JA, Alberio L (2005) Thrombotic thrombocytopenic purpura. J Thromb Haemost 3:1663–1675

    Article  PubMed  Google Scholar 

  24. Schnog JJ, Hovinga JA, Krieg S, Akin S, Lämmle B, Brandjes DP, Mac Gillavry MR, Muskiet FD, Duits AJ, CURAMA Study Group (2006) ADAMTS13 activity in sickle cell disease. Am J Hematol 81:492–498

    Article  PubMed  CAS  Google Scholar 

  25. Shelat SG (2010) Thrombotic thrombocytopenic purpura and sickle cell crisis. Clin Appl Thromb Hemost 16:224–227

    Article  PubMed  Google Scholar 

  26. Mannucci PM, Capoferri C, Canciani MT (2004) Plasma levels of von Willebrand factor regulate ADAMTS-13, its major cleaving protease. Br J Haematol 126:213–218

    Article  PubMed  CAS  Google Scholar 

  27. Zhou Z, Han H, Cruz MA, López JA, Dong JF, Guchhait P (2009) Haemoglobin blocks von Willebrand factor proteolysis by ADAMTS-13: a mechanism associated with sickle cell disease. Thromb Haemost 101:1070–1077

    PubMed  CAS  Google Scholar 

  28. Ono T, Mimuro J, Madoiwa S, Soejima K, Kashiwakura Y, Ishiwata A, Takano K, Ohmori T, Sakata Y (2006) Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure. Blood 107:528–534

    Article  PubMed  CAS  Google Scholar 

  29. Buseri FI, Jeremiah ZA, Shokunbi WA (2006) Plasma levels of some blood coagulation parameters in Nigerian homozygous sickle cell patients (HbSS) in steady state. Hematology 11:375–379

    Article  PubMed  CAS  Google Scholar 

  30. Ataga KI, Key NS (2007) Hypercoagulability in sickle cell disease: new approaches to an old problem. Hematology Am Soc Hematol Educ Program 91–96

  31. Cappellini MD (2007) Coagulation in the pathophysiology of hemolytic anemias. Hematology Am Soc Hematol Educ Program 2007:74–78

    Article  Google Scholar 

  32. Hagger D, Wolff S, Owen J, Samson D (1995) Changes in coagulation and fibrinolysis in patients with sickle cell disease compared with healthy black controls. Blood Coagul Fibrinolysis 6:93–99

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The contribution of Transfusion Medicine technologists Abdulla Ebrahim and Ahmed Al Sekri to the data retrieval of these cases is gratefully acknowledged.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Durjoy K. Shome.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shome, D.K., Ramadorai, P., Al-Ajmi, A. et al. Thrombotic microangiopathy in sickle cell disease crisis. Ann Hematol 92, 509–515 (2013). https://doi.org/10.1007/s00277-012-1647-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-012-1647-3

Keywords

Navigation